Corient Private Wealth’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$109K Buy
+16,000
New +$126K ﹤0.01% 3130

Other funds holding KYTX

Corient Private Wealth's KYTX Position: Q3 2026 in Review

Corient Private Wealth opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 16,000 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #3130 among its holdings.

128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • Corient Private Wealth held 16,000 shares of Kyverna Therapeutics worth $109K as of Q3 2026.
  • Kyverna Therapeutics was a new Corient Private Wealth position in Q3 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3130 holding.
  • 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.